Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
RECELL19.06M97.51%
Other wound care products271K1.39%
Lease revenue152K0.78%
Biomedical Advanced Research and Development Authority (BARDA) revenue for right of first access56K0.29%
Deferred commercial revenue recognized8K0.04%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States46.36M92.45%
Japan3.37M6.72%
Australia222K0.44%
United Kingdom141K0.28%
European Union51K0.10%
